ID
32743
Description
Study ID: 107085 Clinical Study ID: GLP107085 Study Title: A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01406262 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2
Keywords
Versions (1)
- 11/14/18 11/14/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 14, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
The Effect of Albiglutide on Cardiac Repolarisation Compared with Placebo 107085
Screening Visit: Electrocardiogram
- StudyEvent: ODM
Description
ECG
Description
Date ECG Performed
Data type
date
Description
Time ECG Performed
Data type
time
Description
Heart Rate
Data type
integer
Measurement units
- bpm
Description
PR Interval
Data type
float
Measurement units
- msec
Description
QRS Duration
Data type
float
Measurement units
- msec
Description
QT Interval
Data type
float
Measurement units
- msec
Description
QTcF Interval
Data type
float
Measurement units
- msec
Description
QTcB Interval
Data type
float
Measurement units
- msec
Description
RR Interval
Data type
float
Measurement units
- msec
Description
Interpretation of ECG
Similar models
Screening Visit: Electrocardiogram
- StudyEvent: ODM
No comments